Pulmonary involvement is increasingly reported in patients with GATA2 mutations, ranging from opportunistic infections to interstitial lung disease and pulmonary alveolar proteinosis, even in the absence of overt hematopoietic dysfunction. The gene discussed is GATA2; the disease is pulmonary alveolar proteinosis.